Vanquish Oncology

United States
Champaign, Illinois, United States, 61820

Company profile

Vanquish Oncology company profile

Vanquish Oncology is a biotechnology company that develops targeted, small-molecule oncology therapeutics for unmet or underserved cancer markets. It features an advanced program in selectively triggering cancer cell death through activating procaspase 3, a key late-stage effector of apoptosis. The company was founded in 2011 and headquartered in Champaign, Illinois.

Business identity

Contact email
[email protected]
Phone number
510-219-6200
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Postal code
61820
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$6.4M
Last funding
Series Unknown / $1M / 2019-06-19
Last equity funding
Series Unknown / $1M
Investors
1
Founders
1
Articles
1

Founders and investors

Founders

Ted Tarasow

Investors

Illinois Ventures